GlaxoSmithKline LLC recalls Tivicay (dolutegravir) Tablets 50 mg, 30-count Bottle, Rx Only, Manufactured for: ViiV Healthcare RTP, NC 27709, NDC 49702-228-13.
Labeling: incorrect or missing lot and/or expiration date. An incorrect expiration date was printed on the product labeling with an expiration date of January 2027, whereas the correct expiration date is September 2026.
Read the official notice →- Date
- 2022-06-01
- Country
- United States
- Brand
- GlaxoSmithKline
- Product
- Tivicay (dolutegravir) Tablets 50 mg, 30-count Bottle, Rx Only, Manufactured for: ViiV Healthcare RTP, NC 27709, NDC 49702-228-13.
- Classification
- Class III
- Units
- Nationwide in the U.S.
- Category
- Drugs & medical
- Source
- FDA · Drug
Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer
What to do
- Check the product name, strength and lot number against the official notice.
- Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
- Ask the pharmacy or supplier about a replacement or refund.
General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.
More GlaxoSmithKline recalls
- 2024-06-12
USGlaxoSmithKline LLC recalls Tivicay PD (dolutegravir) 5mg Tablets for Oral Suspension, 60-count bottles, Each carton contains one bottle of 60 tablets, one 30-mL…
Labeling: Incorrect Lot and/or Expiration Date: The carton has incorrect expiration of 2026-MAY*, whereas the correct expiration date, which is on the tablet bottle label, is 2025-APR.
- 2024-01-03
- US
GlaxoSmithKline LLC recalls ANORO ELLIPTA (umeclidinium and vilanterol inhalation powder) 62.5 mcg/25mcg. 1 inhaler contains 30 doses (60 blisters total), Rx Only,…
Failed Release Testing: Coarse Particle Mass for umeclidinium Out of Specification
Other drugs & medical recalls in the United States
- 2022-06-01
- US
ARJOHUNTLEIGH POLSKA Sp. z.o.o. recalls Sara Plus Active Floor Lift
The device may emit smoke or ignite.
FDA · DeviceARJOHUNTLEIGH POLSKA Sp. z.o.o.US Nationwide and Worldwide distributionOfficial notice → - US
Calvin Scott & Company, Inc. recalls Benzonatate capsules, 100mg, repackaged in 30-count bottles, Distributed by Calvin Scott & Co., Inc, Albuq., NM. 87123, NDC…
Labeling: Label Mix-up: Bottle labeled as Benzonatate 100 mg capsules contained Benzphetamine 50 mg tablets and a bottle labeled as Benzphetamine 50 mg tablets contained Benzonatate 100 mg capsules.
- US
Olympia Compounding Pharmacy dba Olympia Pharmacy recalls Sodium Bicarbonate 8.4% MDV Injection, Multi-Dose 30 mL vial, Rx Only, Olympia Pharmaceuticals, 6700 Conroy…
Lack of assurance of sterility.
FDA · DrugOlympia Compounding Pharmacy dba Olympia PharmacyDistributed Nationwide in th USA, Puerto Rico and US Virgin IslandsOfficial notice → - US
Direct Rx recalls Losartan Pot/HCTZ 100/12.5 mg 90 Tabs NDC 72189-290-90 Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 Mfg. For Macleods…
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits .
- US
Preferred Pharmaceuticals, Inc. recalls Losartan Potassium & HCTZ Tablets 50mg/12.5 mg, hydrochlorothiazide USP 12.5, Pkg Size: 90, NDC: 68788-7758-09.
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
- US
Eco Lips, Inc recalls Higher Education Make Out Ready Vegan Lip Balm, SPF 15, Net Wt. 0.15 oz (4.25 g) per tube, Active Ingredients: Oxtinoxate (7.5%),…
Mislabeling: The active ingredient list on the label does not match the product's actual ingredients Specifically, the label states Octinoxate 7.5% and Oxybenzone 3%, while the product therein is made with Octinoxate…